Similar Articles
1201 Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma
1202 Usefulness of the MESH score in a European hepatocellular carcinoma cohort
1203 Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma
1204 Image quality and diagnostic performance of free-breathing diffusion-weighted imaging for hepatocellular carcinoma
1205 Hepatitis B virus X protein induces hepatic stem cell-like features in hepatocellular carcinoma by activating KDM5B
1206 Severe esophageal injury after radiofrequency ablation - a deadly complication
1207 Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma
1208 Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
1209 Is there a difference between 19G core biopsy needle and 22G core biopsy needle in diagnosing the correct etiology? - A meta-analysis and systematic review
1210 Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA